Synriam (Arterolane/Piperaquine)

Synriam is a once-daily, 3-day oral antimalarial combining arterolane and piperaquine for effective treatment of uncomplicated P. falciparum malaria, including drug-resistant strains.

pack size Price Add to Cart
30 Tablets - USD $2.87 Per Tablet$86.00
View Cart
60 Tablets - USD $2.58 Per Tablet$155.00
View Cart
90 Tablets - USD $2.21 Per Tablet$199.00
View Cart

Synriam (Arterolane/Piperaquine)

Active IngredientArterolane/Piperaquine
Indication:Malaria
Manufacturer:Sun Pharmaceutical Industries Ltd
Packaging3 Tablets in Strip
Strength150mg/750mg
Delivery Time6 To 15 days

Synriam is a fixed-dose combination antimalarial medication containing Arterolane maleate (150 mg) and Piperaquine phosphate (750 mg), designed for the treatment of uncomplicated malaria, particularly Plasmodium falciparum infections. It is an innovative, once-daily, 3-day oral therapy developed to offer rapid parasite clearance with high efficacy, including against drug-resistant strains.
Arterolane acts quickly to kill malaria parasites during the blood stage, offering fast symptom relief, while Piperaquine has a long half-life that ensures sustained activity, reducing the risk of recurrence. Synriam is the first New Chemical Entity developed and manufactured in India, and it has been included in India’s national malaria control program.

pack size

30 Tablets – USD $2.87 Per Tablet, 60 Tablets – USD $2.58 Per Tablet, 90 Tablets – USD $2.21 Per Tablet

There are no reviews yet.

Be the first to review “Synriam (Arterolane/Piperaquine)”